Sabby Management’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Sabby Management’s Portfolio LYRA Stock Details LYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$51.1K	Sell	104,059 -71,099	-41%	-$130K	0.11%	25
2025 Q4	$539K	Buy	175,158 +47,534	+37%	+$237K	0.78%	11
2025 Q3	$833K	Buy	127,624 +1,895	+2%	+$13.9K	0.96%	11
2025 Q2	$1.13M	Buy	+125,729	New	+$1.04M	2.04%	7

Sabby Management's LYRA Position: Q1 2026 in Review

Sabby Management reduced its LYRA THERAPEUTICS INC (LYRA) stake by 41% in Q1 2026, selling an estimated $130K and leaving 104,059 shares worth $51.1K. The position accounts for 0.11% of the portfolio, ranked #25.

Sabby Management first reported a position in LYRA in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.13M in Q2 2025. 1 fund tracked by Wall St. Rank holds LYRA as of Q1 2026.

Sabby Management held 104,059 shares of LYRA THERAPEUTICS INC worth $51.1K as of Q1 2026.
Sabby Management sold 71,099 LYRA THERAPEUTICS INC shares in Q1 2026, an estimated $130K.
LYRA THERAPEUTICS INC made up 0.11% of Sabby Management's portfolio in Q1 2026, its #25 holding.
Sabby Management first reported a position in LYRA THERAPEUTICS INC in Q2 2025 and has held it in 4 quarters since.
Sabby Management's LYRA THERAPEUTICS INC position peaked at $1.13M in Q2 2025.
1 fund tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2026.

Based on Sabby Management's 13F filing for Q1 2026, filed 15 May 2026.